Candriam Equities L Biotechnology Class C USD Cap

Performance History30/06/2020
Growth of 1,000 (GBP) Advanced Graph
Candriam Equities L Biotechnology Class C USD Cap
Fund-4.015.7-5.729.818.3
+/-Cat-0.15.42.29.6-3.6
+/-B’mrk2.24.6-2.59.5-3.7
 
Key Stats
NAV
10/07/2020
 USD 756.58
Day Change -1.05%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0108459040
Fund Size (Mil)
10/07/2020
 USD 1981.64
Share Class Size (Mil)
10/07/2020
 USD 411.62
Max Initial Charge 3.50%
Ongoing Charge
06/04/2020
  1.88%
Morningstar Research
Analyst Report

A team of highly qualified biotechnology experts led by one of the industry’s most seasoned investors in the field, and a proven process, give this fund an edge. Under our enhanced ratings framework, which puts more focus on fees and expected...

Click here to read this analyst report on the underlying fund.
Morningstar Pillars
PeopleAbove Average
ParentAverage
ProcessAbove Average
Performance
Price
Investment Objective: Candriam Equities L Biotechnology Class C USD Cap
The objective of the sub-fund is to benefit from the performance of the market in global equities of companies in the biotechnology sector, on the basis of discretionary management.
Returns
Trailing Returns (GBP)10/07/2020
YTD17.26
3 Years Annualised12.62
5 Years Annualised8.86
10 Years Annualised20.36
12 Month Yield 0.00
Management
Manager Name
Start Date
Rudi Van den Eynde
06/04/2000
Servaas Michielssens
01/01/2019
Inception Date
06/04/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDNASDAQ Biotechnology TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Candriam Equities L Biotechnology Class C USD Cap30/04/2020
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock92.560.0092.56
Bond0.000.000.00
Property0.000.000.00
Cash7.570.137.44
Other0.000.000.00
Top 5 Regions%
United States85.77
Eurozone6.15
Europe - ex Euro3.33
Asia - Emerging2.01
Japan1.62
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Vertex Pharmaceuticals IncHealthcareHealthcare7.31
Biogen IncHealthcareHealthcare6.29
Gilead Sciences IncHealthcareHealthcare6.11
Amgen IncHealthcareHealthcare5.19
Regeneron Pharmaceuticals IncHealthcareHealthcare4.71
Candriam Equities L Biotechnology Class C USD Cap

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies